Literature DB >> 27316343

Rats taste-aversive learning with cyclosporine a is not affected by contextual changes.

Akin Tuerkmen1, Katharina Bösche1, Laura Lückemann1, Harald Engler1, Manfred Schedlowski1, Martin Hadamitzky2.   

Abstract

In conditioned taste aversion (CTA) rats associate a novel taste (conditioned stimulus; CS) with a treatment (unconditioned stimulus; US) that induces symptoms of malaise. During retrieval, animals learn that the CS no longer predicts the US, with the consequence that the behavior elicited by the CS extinguishes. Importantly, CTA data with lithium chloride (LiCl) as US indicate that extinction learning is affected by changing the physical context. However, if this is also the case in different taste-aversion paradigms employing compounds other than LiCL as US is unknown. Against this background the present study investigated in a CTA paradigm with saccharin as CS and the immunosuppressant cyclosporine A (CsA) as US the influence of contextual changes on CTA extinction. Our results show, that extinction of a learned CS-US association with CsA is not prone to contextual changes. Due to the direct effects of CsA on CNS functioning, CTA with this immunosuppressant apparently operates under different mechanisms compared to other drugs, such as LiCl. These data indicate that taste aversive learning and its extinction are not necessarily specific to the context in which it is learned but also depends, at least in part, on the physiological and neuropharmacological effects of the drug employed as US.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behavioral conditioning; CTA; Contextual cues; Cyclosporine A; Extinction,

Mesh:

Substances:

Year:  2016        PMID: 27316343     DOI: 10.1016/j.bbr.2016.06.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  1 in total

1.  The effects of hyperbaric oxygen therapy on neuropathic pain via mitophagy in microglia.

Authors:  Guang Han; Kun Liu; Lu Li; Xingyue Li; Ping Zhao
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.